The Business Research Company’s Real-Time CGM Patch Global Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, March 6, 2026 /EINPresswire.com/ — The real-time blood glucose CGM patch market is dominated by a mix of global medical device manufacturers and specialized diabetes technology providers. Companies are focusing on advanced sensor technologies, extended-wear and factory-calibrated systems, seamless smartphone and insulin pump integration, and enhanced data analytics platforms to strengthen market presence and improve clinical outcomes. Emphasis on regulatory compliance, reimbursement expansion, product accuracy, and digital health ecosystem integration remains central to competitive positioning. Understanding the competitive landscape is essential for stakeholders seeking growth opportunities, technological innovation, and strategic partnerships within the rapidly evolving diabetes care and remote patient monitoring sector.
Which Market Player Is Leading the Real-Time Blood Glucose CGM Patch Market?
• According to our research, Abbott Laboratories (FreeStyle) led global sales in 2024 with a 13% market share. The diabetes care division of the company, which is directly involved in the real-time blood glucose CGM patch market, offers a comprehensive portfolio of wearable continuous glucose monitoring systems, including factory-calibrated sensors with extended wear duration and smartphone connectivity. Through its FreeStyle Libre platform, Abbott provides real-time glucose tracking, integrated digital data management solutions, and broad global distribution, supporting diabetes management across both Type 1 and Type 2 patient populations.
Who Are The Major Players In The Real-Time Blood Glucose CGM Patch Market?
Major companies operating in the real-time blood glucose CGM patch market are Abbott Laboratories (FreeStyle), Dexcom, Inc., F. Hoffmann-La Roche AG, Zhejiang POCTech Co.,Ltd, Medtronic PLC, Senseonics Holdings, Inc. (Eversense), MicroTech Medical, Inc., A. Menarini Diagnostics, Biolinq, Metronom Health, Medtrum Technologies Inc., Afon Technology, Nemaura Medical Inc., Ultrahuman Healthcare Pvt Ltd.
How Concentrated Is The Real-Time Blood Glucose CGM Patch Market?
The market is fairly concentrated, with the top 10 players accounting for 32% of total market revenue in 2024. This level of concentration reflects high technological and regulatory entry barriers, driven by stringent medical device approval requirements, clinical validation standards, advanced sensor engineering capabilities, data accuracy expectations, and the need for strong reimbursement and distribution networks. Leading players such as Abbott Laboratories (FreeStyle), Dexcom, Inc., F. Hoffmann-La Roche AG, Zhejiang POCTech Co.,Ltd, Medtronic PLC, Senseonics Holdings, Inc. (Eversense), MicroTech Medical, Inc., A. Menarini Diagnostics, Biolinq, Metronom Health hold notable market shares through diversified CGM portfolios, strong brand recognition, global commercialization capabilities, and continuous innovation in sensor technology and digital health integration. As demand for real-time, minimally invasive glucose monitoring solutions increases, strategic partnerships, technological advancements, and geographic expansion are expected to further strengthen the competitive positioning of these leading companies in the market.
• Leading companies include:
o Abbott Laboratories (FreeStyle) (13%)
o Dexcom, Inc. (12%)
o F. Hoffmann-La Roche AG (4%)
o Zhejiang POCTech Co.,Ltd (1%)
o Medtronic PLC (1%)
o Senseonics Holdings, Inc. (Eversense) (0.4%)
o MicroTech Medical, Inc. (0.4%)
o A. Menarini Diagnostics (0.4%)
o Biolinq (0.3%)
o Metronom Health (0.2%)
Request A Free Sample Of The Real-Time Blood Glucose CGM Patch Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=29165&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Mar_PR
Who Are The Key Raw Material Suppliers In The Real-Time Blood Glucose CGM Patch Market?
• Major raw materials suppliers in the real-time blood glucose CGM patch market include Dow Inc., DuPont de Nemours Inc., 3M Company, Henkel AG & Co. KGaA, BASF SE, Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive Performance Materials Inc., Texas Instruments Incorporated, Analog Devices Inc., NXP Semiconductors N.V., STMicroelectronics N.V., TE Connectivity Ltd., Heraeus Holding GmbH, and DSM-Firmenich.
Who Are The Major Wholesalers And Distributors In The Real-Time Blood Glucose CGM Patch Market?
• Major wholesalers or distributors in the real-time blood glucose CGM patch market include McKesson Corporation, Cardinal Health Inc., Cencora (AmerisourceBergen), Medline Industries LP, Henry Schein Inc., Owens & Minor Inc., Concordance Healthcare Solutions, Morris & Dickson Co. LLC, FFF Enterprises Inc., Anda Inc., Phoenix Group, Zuellig Pharma Holdings Pte Ltd, Sinopharm Group Co. Ltd, Medipal Holdings Corporation, and EBOS Group Limited.
Who Are The Major End Users Of The Real-Time Blood Glucose CGM Patch Market?
• Major end users in the real-time blood glucose CGM patch market include Mayo Clinic, Cleveland Clinic, Johns Hopkins Health System, Kaiser Permanente, HCA Healthcare, Ascension Health, Mount Sinai Health System, NHS England Trusts, Apollo Hospitals Enterprise Ltd., Fortis Healthcare Ltd., Ramsay Health Care Limited, Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Mediclinic International plc, and Bumrungrad International Hospital.
What Are the Major Competitive Trends In The Market?
• Regulatory approvals and extended-wear product innovations are transforming the real-time blood glucose CGM patch market by expanding market access, strengthening clinical validation, and enhancing user convenience and device accuracy.
• Example: In April 2025, DexCom, Inc. received U.S. Food and Drug Administration (FDA) clearance for the Dexcom G7 15 Day Continuous Glucose Monitoring System.
• The system offers up to 15.5 days of sensor wear, hands-free glucose tracking via Apple Watch, and integration with certain automated insulin delivery systems, enabling improved glucose management, fewer monthly sensor replacements, reduced waste, and remote data sharing.
Which Strategies Are Companies Adopting To Stay Ahead?
• Innovating Water-Resistant Sensor Technologies To Enhance Device Durability
• Launching Next-Generation Water-Resistant Continuous Glucose Monitoring Systems With Extended Wear Duration
• Strategic Investments In Research And Development To Advance Sensor Accuracy, Miniaturization
• Aligning With Government Health Initiatives To Expand Adoption Of Wearable Health Monitoring Technologies Across Broader Patient Populations
Access The Detailed Real-Time Blood Glucose CGM Patch Market Report Here:
https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-cgm-patch-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Mar_PR
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 17,500 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.
Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
